{"product_id":"endoscopic-submucosal-dissection-market-by-product-grasp-clips-gastroscopes-colonoscopes-indication-cancer-esophageal-stomach-colon-end-user-hospitals-ambulatory-surgical-centers-specialty-clinics-global-forecast-to-2027","title":"Endoscopic Submucosal Dissection Market by Product (Grasp, Clips, Gastroscopes, Colonoscopes), Indication (Cancer (Esophageal, Stomach, Colon), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) - Global Forecast to 2027","description":"\u003cp\u003eEndoscopic Submucosal Dissection Market by Product (Grasp, Clips, Gastroscopes, Colonoscopes), Indication (Cancer (Esophageal, Stomach, Colon), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) - Global Forecast to 2027\u003c\/p\u003e\n\n\u003cp\u003eThe global endoscopic submucosal dissection market is projected to reach USD 483 million by 2027 from USD 347 million in 2022, at a CAGR of 6.9%.\u003c\/p\u003e\n\n\u003cp\u003eEndoscopic submucosal dissection (ESD) is an advanced therapeutic endoscopy technique for superficial gastrointestinal neoplasms. In endoscopic submucosal dissection, the equipment includes different types of knives, forceps, snares, and a few other products that support the procedure, as well as accessories used to ease the handling of instruments during surgeries.\u003c\/p\u003e\n\n\u003cp\u003eThe global endoscopic submucosal dissection market is projected to reach USD 483 million by 2027 from USD 347 million in 2022, at a CAGR of 6.9%. Growth in this market is largely driven by the increasing use of endoscopy in detection and treatment procedures, the rising prevalence of cancer, and the growing geriatric population. On the other hand, the dearth of skilled professionals is a key factor restraining the growth of this market.\u003c\/p\u003e\n\n\u003cp\u003eThe gastroscopes and colonoscopes segment accounted for the largest share of the global endoscopic submucosal dissection market\u003c\/p\u003e\n\n\u003cp\u003eIn 2021, the gastroscopes and colonoscopes segment holds the largest share of the global endoscopic submucosal dissection market. The large share of this segment can be attributed to the higher adoption rate of this equipment by end users, the rising preference of patients and doctors for minimally invasive procedures, and ongoing technological advancements in endoscopy procedures.\u003c\/p\u003e\n\n\u003cp\u003eThe stomach cancer segment accounted for the largest share of the endoscopic submucosal dissection market in 2021\u003c\/p\u003e\n\n\u003cp\u003eBased on indication, the endoscopic submucosal dissection market is segmented into esophageal cancer stomach cancer, colon cancer. The stomach cancer segment holds the largest share of the endoscopic submucosal dissection market in 2021. The large share of this segment can be attributed to the increasing geriatric population in the US, China, Japan, and India and the rising incidence of stomach cancer.\u003c\/p\u003e\n\n\u003cp\u003eThe hospitals' segment is expected to dominate the endoscopic submucosal dissection market during the forecast period\u003c\/p\u003e\n\n\u003cp\u003eBased on end user, the endoscopic submucosal dissection market is segmented into ambulatory surgical centers, hospitals, specialty clinics, and other end users. The hospitals segment holds the largest share of the endoscopic submucosal dissection market during the forecast period owing to the the increasing per capita income and growing healthcare awareness.\u003c\/p\u003e\n\n\u003cp\u003eNorth America dominated the endoscopic submucosal dissection market in 2021\u003c\/p\u003e\n\n\u003cp\u003eNorth America dominated the endoscopic submucosal dissection market in 2021. The large share of North America in the global market is attributed to the favorable reimbursement policies for endoscopic procedures in the US, the increasing prevalence of cancer, high investments by hospitals to purchase new equipment and adopt new endoscopic procedures, strong focus on research activities to improve endoscopy techniques, as well as the implementation of a new funding model by Canadian hospitals.\u003c\/p\u003e\n\n\u003cp\u003eThe study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:\u003c\/p\u003e \n\n\u003cp\u003eBy Company Type– Tier 1- 34%, Tier 2- 38% Tier 3 - 28%\u003c\/p\u003e \n\n\u003cp\u003eBy Designation— C level - 26%, Managers \u0026amp; Other Level - 74%\u003c\/p\u003e \n\n\u003cp\u003eBy Region— North America - 17%, Europe - 39%, Asia Pacific - 28%\u003c\/p\u003e \n\n\u003cp\u003eKey players in the endoscopic submucosal dissection market\u003c\/p\u003e \n\n\u003cp\u003eThe prominent players in the endoscopic submucosal dissection market are Olympus Corporation (Japan), Boston Scientific Corporation (US), Sumitomo Bakelite Co., Ltd. (Japan), Creo Medical Group PLC (UK), Medtronic (Ireland), HOYA Corporation (Japan), ConMed Corporation (US), Steris Plc (Ireland), FUJIFILM Holdings Corporation (Japan), MTW Endoskopie Manufaktur (Germany), Ovesco Endoscopy AG (Germany), Zeon Medical Inc. (Japan), Micro-Tech Endoscopy (China), Karl Storz SE \u0026amp; CO. KG (Germany), Cook Medical (US), Leo Medical Co., Ltd. (China), Erbe Elektromedizin GmbH (Germany), Taewoong Medical Co., Ltd. (South Korea), DCC Healthcare Limited (Ireland), Kossen Co., Ltd. (South Korea), INNOVAMEDICA S.p.A. (Italy), Jiangsu Vedkang Medical Science and Technology Co., Ltd. (China), Hangzhou AGS Medical Technological Co., Ltd. (China), and Beijing ZKSK Technology Co., Ltd. (China).\u003c\/p\u003e\n\n \u003cp\u003eResearch Coverage:\u003c\/p\u003e\n\n\u003cp\u003eThe report analyzes the endoscopic submucosal dissection market and aims at estimating the market size and future growth potential of this market based on various segments such asproduct, indication, end user and region. The report also includes a product portfolio matrix of various endoscopic submucosal dissection products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.\u003c\/p\u003e \n\n\u003cp\u003eReasons to Buy the Report\u003c\/p\u003e \n\n\u003cp\u003eThe report will enrich established firms as well as new entrants\/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.\u003c\/p\u003e\n\n\u003cp\u003eThis report provides insights into the following pointers:\u003c\/p\u003e\n\n\u003cp\u003eMarket Penetration: Comprehensive information on product portfolios offered by the top players in the global endoscopic submucosal dissection market. The report analyzes this market by product, indication, end user and region.\u003c\/p\u003e\n\n\u003cp\u003eProduct Enhancement\/Innovation: Detailed insights on upcoming trends and product launches in the global endoscopic submucosal dissection market.\u003c\/p\u003e \n\n\u003cp\u003eMarket Development: Comprehensive information on the lucrative emerging markets byproduct, indication, end user and region.\u003c\/p\u003e\n\n\u003cp\u003eMarket Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global endoscopic submucosal dissection market.\u003c\/p\u003e\n\n\u003cp\u003eCompetitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global endoscopic submucosal dissection market.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ 197 Pages \/ MCW16239576","offer_id":47656696774962,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/endoscopic-submucosal-dissection-market-by-product-grasp-clips-gastroscopes-colonoscopes-indication-cancer-esophageal-stomach-colon-end-user-hospitals-ambulatory-surgical-centers-specialty-clinics-global-forecast-to-2027","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}